References
- Pear Therapeutics, Inc. Pear therapeutics press release [Internet]. Boston (MA): Pear Therapeutics; 2021 [cited 2021 September 22]. Available from: https://peartherapeutics.com/fda-obtains-fda-clearance-first-prescription-digital-therapeutic-treat-disease/.
- Golinelli D, Boetto E, Carullo G, Nuzzolese AG, Landini MP, Fantini MP. Adoption of digital technologies in health care during the COVID-19 pandemic: systematic review of early scientific literature. J Med Internet Res 2020;22:e22280.
- Kataria S, Ravindran V. Digital health: a new dimension in rheumatology patient care. Rheumatol Int 2018;38:1949-57.
- Kim HS. Apprehensions about excessive belief in digital therapeutics: points of concern excluding merits. J Korean Med Sci 2020;35:e373.
- Shim JS, Oh K, Jung SJ, Kim HC. Self-reported diet management and adherence to dietary guidelines in Korean adults with hypertension. Korean Circ J 2020;50:432-40.
- Cheung BMY, Or B, Fei Y, Tsoi MF. A 2020 vision of hypertension. Korean Circ J 2020;50:469-75.
- U.S. Food and Drug Administration. Enforcement policy for digital health devices for treating psychiatric disorders during the coronavirus disease 2019 (COVID-19) public health emergency [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2020 [cited 2021 March 27]. Available from: https://www.fda.gov/media/136939/download.
- Gesetzesbeschluss des Deutschen Bundestages (Legislature, German Federal Parliament). Gesetz fur eine bessere Versorgung durch Digitalisierung und Innovation (Digitale-Versorgung-Gesetz - DVG) (Nov. 29, 2019).
- Ministry of Food and Drug Safety. Guidelines on review and approval of digital therapeutics [Internet]. Cheongju: Ministry of Food and Drug Safety; 2020 [cited 2021 March 27]. Available from: https://www.mfds.go.kr/eng/brd/m_40/view.do?seq=72624&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1.
- Digital Therapeutics Alliance. Digital therapeutics definition and core principles [Internet]. [place unknown]: Digital Therapeutics Alliance; 2019 [cited 2021 March 27]. Available from: https://dtxalliance.org/wp-content/uploads/2021/01/DTA_DTx-Definition-and-Core-Principles.pdf.
- Bundesinstitut fur Arzneimittel und Medizinprodukte. DiGA [Internet]. Bonn: Bundesinstitut fur Arzneimittel und Medizinprodukte; 2021 [cited 2021 May 27]. Available from: https://diga.bfarm.de/.
- CureApp, Inc. CureApp hypertension therapeutics app clinical trial results announced at ESC congress 2021 and published in the European Heart Journal, a leading cardiovascular journal [Internet]. Tokyo: CureApp, Inc.; 2021 [cited 2021 September 22]. Available from: https://cureapp-en.blogspot.com/.
- Jeon YW, Kim HC. Factors associated with awareness, treatment, and control rate of hypertension among Korean young adults aged 30-49 years. Korean Circ J 2020;50:1077-91.
- Lee HY, Oh GC, Sohn IS, et al. Suboptimal management status of younger hypertensive population in Korea. Korean Circ J 2021;51:598-606.
- Bundesinstitut fur Arzneimittel und Medizinprodukte. The fast-track process for digital health applications (DiGA) according to section 139e SGB V [Internet]. Bonn: Bundesinstitut fur Arzneimittel und Medizinprodukte; 2020 [cited 2021 April 13]. Available from: https://www.bfarm.de/SharedDocs/Downloads/EN/MedicalDevices/DiGA_Guide.html.
- U.S. Food and Drug Administration. Policy for device software functions and mobile medical applications [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2019 [cited 2021 March 27]. Available from: https://www.fda.gov/media/80958/download.
- National Institute for Health and Care Excellence. Evidence standards framework for digital health technologies [Internet]. London: National Institute for Health and Care Excellence; 2019 [cited 2021 March 27]. Available from: https://www.nice.org.uk/Media/Default/About/what-we-do/our-programmes/evidence-standards-framework/digital-evidence-standards-framework.pdf.
- National Health Services. NHS mental health implementation plan 2019/20-2023/24 [Internet]. London: National Health Services; 2019 [cited 2021 March 27]. Available from: https://www.longtermplan.nhs.uk/wp-content/uploads/2019/07/nhs-mental-health-implementation-plan-2019-20-2023-24.pdf.
- National Health Services. The improving access to psychological therapies manual [Internet]. London: National Health Services; 2018 [cited 2021 April 13]. Available from: https://www.england.nhs.uk/wpcontent/uploads/2018/06/the-iapt-manual-v5.pdf.
- Ministry of Health, Labour and Welfare of Japan. Guidelines for medical device applicability of the program [Internet]. Tokyo: Ministry of Health, Labour and Welfare of Japan; 2021 [cited 2021 April 13]. Available from: https://www.mhlw.go.jp/content/11120000/000764274.pdf.
- Australian Therapeutic Goods Act 1989, Pub. L. No. 21, 1990 (Jan 1, 2019).
- Therapeutic Goods Administration. How the TGA regulates software based medical devices [Internet]. Woden: Therapeutic Goods Administration; 2021 [cited 2021 April 20]. Available from: https://www.tga.gov.au/sites/default/files/how-tga-regulates-software-based-medical-devices.pdf.
- National Evidence-based Healthcare Collaborating Agency. Guidance to new healthcare technology evaluation system A to Z [Internet]. Seoul: National Evidence-based Healthcare Collaborating Agency; 2020 [cited 2021 May 25]. Available from: https://nhta.neca.re.kr/nhta/publication/nhtaU0605V.ecg?seq=8975.
- Centers for Medicare & Medicaid Services. Medicare program; Medicare Coverage of Innovative Technology (MCIT) and definition of "Reasonable and Necessary"; Delay of effective date. Final rules. Fed Regist 2021;86:26849-54.
- Centers for Medicare & Medicaid Services. Medicare program; Medicare Coverage of Innovative Technology (MCIT) and definition of "Reasonable and Necessary." Final rules. Fed Regist 2021;86:2987-3010.
- Centers for Medicare & Medicaid Services. Medicare program; Medicare Coverage of Innovative Technology (MCIT) and definition of "Reasonable and Necessary." Final rules. Fed Regist 2021;86:62944-58.
- National Health Services. Test beds programme information to support the launch of wave 2 [Internet]. London: National Health Services; 2018 [cited 2021 April 21]. Available from: https://www.england.nhs.uk/wp-content/uploads/2018/04/test-beds-supporting-information-wave-2-competition.pdf.
- National Health Services. MedTech funding mandate policy 2021/22 [Internet]. London: National Health Services; 2021 [cited 2021 April 21]. Available from: https://www.england.nhs.uk/aac/wp-content/uploads/sites/50/2021/01/mtfm-policy-guidance-jan-2021.pdf.
- National Health Services. 2020/21 National tariff payment system [Internet]. London: National Health Services; 2020 [cited 2021 April 21]. Available from: https://www.england.nhs.uk/wp-content/uploads/2021/02/20-21_National-Tariff-Payment-System.pdf.
- Gemeinsamer Bundesausschuss Innovationsausschuss. Forderbekanntmachung Seite des Innovationsausschusses beim Gemeinsamen Bundesausschuss zur themenoffenen Forderung von neuen Versorgungsformen gemass § 92a Absatz 1 des Fuften Buches Sozialgesetzbuch (SGB V) zur Weiterentwicklung der Versorgung in der gesetzlichen Krankenversicherung (zweistufiges Verfahren) [Internet]. Berlin: Gemeinsamer Bundesausschuss Innovationsausschuss; 2021 [cited 2021 April 13]. Available from: https://innovationsfonds.g-ba.de/downloads/media/245/2021-03-17_Foerderbekanntmachung_NVF_themenoffen_2021.pdf.
- Ministry of Health, Labour and Welfare of Japan. DX (Digital Transformation) action strategies in healthcare for SaMD (Software as a Medical Device) [Internet]. Tokyo: Ministry of Health, Labour and Welfare of Japan; 2020 [cited 2021 April 13]. Available from: https://www.mhlw.go.jp/content/11124500/000737470.pdf.
- Australian Government, Australian Digital Health Agency. Australia's national digital health strategy [Internet]. Sydney: Australian Digital Health Agency; 2017 [cited 2021 May 25]. Available from: https://apo.org.au/sites/default/files/resource-files/2017-08/apo-nid182181.pdf.
- University of Canberra. Mobile health: empowering people with type 2 diabetes using digital tools [Internet]. Canberra: University of Canberra; 2016 [cited 2021 November 23]. Available from: https://www.canberra.edu.au/research/faculty-research-centres/nmrc/research/mobile-digital-communication-and-healthmanagement/Mobile-Health-Empowering-people-with-type-2-diabetes-using-digital-tools-updated-v2.pdf.
- Health Insurance Review and Assessment Service. Roles and functions of health insurance review and assessment service [Internet]. Wonju: Health Insurance Review and Assessment Service; 2021 [cited 2021 May 25]. Available from: https://repository.hira.or.kr/handle/2019.oak/2523.
- Health Insurance Review and Assessment Service. Guidelines on national health insurance benefits coverage for new and innovative healthcare technology. AI-based healthcare technology (medical imaging) & introduction of 3D printing to healthcare technology [Internet]. Wonju: Health Insurance Review and Assessment Service; 2019 [cited 2021 May 25]. Available from: https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020041000100&brdScnBltNo=4&brdBltNo=10255#none.
- Centers for Medicare & Medicaid Services. Medicare program; revised process for making national coverage determinations. Notice. Fed Regist 2013;78:48164-69.
- Premera Blue Cross. Medical policy-13.012.500. Prescription digital therapeutics [Internet]. Mountlake Terrace (WA): Premera Blue Cross; 2021 [cited 2021 November 23]. Available from: https://www.premera.com/medicalpolicies/13.01.500.pdf.
- UK Department of Health and Social Care. Accelerated access review. Final report [Internet]. London: UK Department of Health and Social Care; 2016 [cited 2021 May 20]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/565072/AAR_final.pdf.
- National Institute for Health and Care Excellence. Process and methods statement for the production of NICE IAPT assessment briefings (IABs) [Internet]. London: National Institute for Health and Care Excellence; 2019 [cited 2021 May 20]. Available from: https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-advice/IAPT/IAB-process-and-methods-statement.pdf.
- National Institute for Health and Care Excellence. Process and methods statement for the production of NICE IAPT evaluation in practice reports [Internet]. London: National Institute for Health and Care Excellence; 2019 [cited 2021 May 20]. Available from: https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-advice/IAPT/IEPR-process-methods.pdf.
- National Institute for Health and Care Excellence. Space from depression for treating adults with depression [Internet]. London: National Institute for Health and Care Excellence; 2020 [cited 2021 May 20]. Available from: https://www.nice.org.uk/advice/mib215/resources/space-from-depression-for-treating-adults-with-depression-pdf-2285965453227973.
- Bundesinstitut fur Arzneimittel und Medizinprodukte. DiGA directory [Internet]. Bonn: Bundesinstitut fur Arzneimittel und Medizinprodukte; 2021 [cited 2021 May 27]. Available from: https://diga.bfarm.de/de/verzeichnis.
- Ministry of Health, Labour and Welfare of Japan. Handling of medical device insurance coverage, etc. [Internet]. Tokyo: Ministry of Health, Labour and Welfare of Japan; 2019 [cited 2021 April 13]. Available from: https://www.mhlw.go.jp/content/000497471.pdf.
- Ministry of Health, Labour and Welfare of Japan. Criteria for calculating insurance redemption prices for specified insurance medical materials [Internet]. Tokyo: Ministry of Health, Labour and Welfare of Japan; 2019 [cited 2021 April 13]. Available from: https://www.mhlw.go.jp/content/000497470.pdf.
- Ministry of Health, Labour and Welfare of Japan. Insurance coverage for medical devices [Internet]. Tokyo: Ministry of Health, Labour and Welfare of Japan; 2020 [cited 2021 April 13]. Available from: https://www.mhlw.go.jp/content/12404000/000693018.pdf.
- CureApp, Inc. CureApp and Jichi Medical University collaborate on a hypertension therapeutics app Primary endpoint met in Phase III clinical trial in Japan. [Internet]. Tokyo: CureApp, Inc.; 2021 [cited 2021 December 2]. Available from: https://cureapp-en.blogspot.com/2021/03/cureapp-and-jichi-medical-university.html.
- Medicare Services Advisory Committee. Frequently asked questions [Internet]. [place unknown]: Medicare Services Advisory Committee; 2019 [cited 2021 June 1]. Available from: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/FAQ-01.
- Medicare Services Advisory Committee. Process framework [Internet]. [place unknown]: Medicare Services Advisory Committee; 2016 [cited 2021 May 25]. Available from: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/FFDFEFDA8B25248FCA25801000123AD3/$File/Final%20Process%20Framework.pdf.